The peptide is primarily studied for its potential to influence pigmentation Melanotan-2 (MT-2), a synthetic peptide derived ...

"Our results uncover a mechanism by which the nonvisual opsin receptor OPN3 modulates food intake via the melanocortin 4 ...

Palatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin 4 receptor (MC4R) bremelanotide with tirzepatide, a glucagon-like peptide-1 (GLP ...

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system.

"Our results uncover a mechanism by which the nonvisual opsin receptor OPN3 modulates food intake via the melanocortin 4 receptor MC4R, which is crucial for regulating energy balance and feeding ...

She first joined the Centre for Endocrinology in 2005 to undertake her PhD investigating a novel receptor trafficking protein MRAP2 (melanocortin receptor accessory protein two). This was funded by a ...